Kardigan

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.

Cardiatec

This company develops an artificial intelligence platform to identify novel drug targets and therapeutics for cardiovascular diseases for the pharmaceutical and healthcare industries.

CardiaTec Biosciences

This company develops an artificial intelligence platform to identify cardiovascular drug targets for pharmaceutical providers using large-scale multi-omics data.

preCARDIA

This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

Cardior Pharmaceuticals

This biopharmaceutical company develops RNA-based therapeutics to prevent and repair heart disease for patients with conditions such as heart failure and myocardial infarction.

Cardiatech Bio

The company develops a computational platform to discover cardiovascular drug targets using multi-omics data for the pharmaceutical and biotechnology industries.